Differentiated Thyroid Carcinoma: Risk Group Assignment and Management Controversies

Pascal Fuchshuber; Thom R. Loree; Mark D. Delacure; Wesley L. Hicks

Differentiated Thyroid Carcinoma: Risk Group Assignment and Management Controversies

Pascal Fuchshuber
, Thom R. Loree
, Mark D. Delacure
, Wesley L. Hicks

Surgery

Department of Head
Roswell Park Cancer Institute

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

In this review, we provide a framework for clinical decision-making in the treatment of differentiated thyroid cancer. The clinical discussion and treatment recommendations are relevant to an adult population (>16 years of age). The natural history, pathogenesis, diagnostic tools, and treatment controversies in the management of this disease are explored. The roles of radioiodine therapy and thyroid-stimulating hormone (TSH) suppression and the treatment of locoregional disease are reviewed. This discussion provides a comprehensive assessment of management and treatment issues in differentiated thyroid cancer.

Original language	English
Pages (from-to)	99-106
Number of pages	8
Journal	Oncology
Volume	12
Issue number	1
State	Published - 1998

Cite this

@article{823df48af1904d128dad8116dfbd17c4,

title = "Differentiated Thyroid Carcinoma: Risk Group Assignment and Management Controversies",

abstract = "In this review, we provide a framework for clinical decision-making in the treatment of differentiated thyroid cancer. The clinical discussion and treatment recommendations are relevant to an adult population (>16 years of age). The natural history, pathogenesis, diagnostic tools, and treatment controversies in the management of this disease are explored. The roles of radioiodine therapy and thyroid-stimulating hormone (TSH) suppression and the treatment of locoregional disease are reviewed. This discussion provides a comprehensive assessment of management and treatment issues in differentiated thyroid cancer.",

author = "Pascal Fuchshuber and Loree, \{Thom R.\} and Delacure, \{Mark D.\} and Hicks, \{Wesley L.\}",

year = "1998",

language = "English",

volume = "12",

pages = "99--106",

journal = "Oncology",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

number = "1",

}

TY - JOUR

T1 - Differentiated Thyroid Carcinoma

T2 - Risk Group Assignment and Management Controversies

AU - Fuchshuber, Pascal

AU - Loree, Thom R.

AU - Delacure, Mark D.

AU - Hicks, Wesley L.

PY - 1998

Y1 - 1998

N2 - In this review, we provide a framework for clinical decision-making in the treatment of differentiated thyroid cancer. The clinical discussion and treatment recommendations are relevant to an adult population (>16 years of age). The natural history, pathogenesis, diagnostic tools, and treatment controversies in the management of this disease are explored. The roles of radioiodine therapy and thyroid-stimulating hormone (TSH) suppression and the treatment of locoregional disease are reviewed. This discussion provides a comprehensive assessment of management and treatment issues in differentiated thyroid cancer.

AB - In this review, we provide a framework for clinical decision-making in the treatment of differentiated thyroid cancer. The clinical discussion and treatment recommendations are relevant to an adult population (>16 years of age). The natural history, pathogenesis, diagnostic tools, and treatment controversies in the management of this disease are explored. The roles of radioiodine therapy and thyroid-stimulating hormone (TSH) suppression and the treatment of locoregional disease are reviewed. This discussion provides a comprehensive assessment of management and treatment issues in differentiated thyroid cancer.

UR - https://www.scopus.com/pages/publications/0031883063

M3 - Article

C2 - 9474590

AN - SCOPUS:0031883063

SN - 0890-9091

VL - 12

SP - 99

EP - 106

JO - Oncology

JF - Oncology

IS - 1

ER -

Differentiated Thyroid Carcinoma: Risk Group Assignment and Management Controversies

Abstract

Other files and links

Fingerprint

Cite this